Cargando…

A multivariate analysis of tumour biological factors predicting response to cytotoxic treatment in advanced breast cancer.

The study was designed to identify factors that could predict response to chemotherapy in breast cancer. A total of 173 patients with measurable or evaluable metastatic breast cancer were enrolled in a randomized trial between November 1987 and January 1991 to receive a monthly dose of 5-fluorouraci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sjöström, J., Krajewski, S., Franssila, K., Niskanen, E., Wasenius, V. M., Nordling, S., Reed, J. C., Blomqvist, C.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group\|1 1998
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2062970/ https://www.ncbi.nlm.nih.gov/pubmed/9743306

Ejemplares similares

Do DNA ploidy and S-phase fraction in primary tumour predict the response to chemotherapy in metastatic breast cancer?
por: Hietanen, P., et al.
Publicado: (1995)

Predictive value of c-erbB-2, p53, cathepsin-D and histology of the primary tumour in metastatic breast cancer.
por: Niskanen, E., et al.
Publicado: (1997)

Comparison of benign and malignant follicular thyroid tumours by comparative genomic hybridization.
por: Hemmer, S., et al.
Publicado: (1998)

Tumour growth rate and DNA flow cytometry parameters as prognostic factors in metastatic melanoma.
por: Muhonen, T., et al.
Publicado: (1992)

Cyclin A as a marker for prognosis and chemotherapy response in advanced breast cancer
por: Poikonen, P, et al.
Publicado: (2005)

HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review
por: Carlsson, J, et al.
Publicado: (2004)

Tumour microvessel density as predictor of chemotherapy response in breast cancer patients
por: Tynninen, O, et al.
Publicado: (2002)

Improved ability of biological and previous caries multimarkers to predict caries disease as revealed by multivariate PLS modelling
por: Nordlund, Åke, et al.
Publicado: (2009)

Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factors
por: Jahkola, T, et al.
Publicado: (1999)

The prognostic value of DNA-ploidy in colorectal carcinoma: a prospective study.
por: Kouri, M., et al.
Publicado: (1990)

Breast cancer outcome prediction with tumour tissue images and machine learning
por: Turkki, Riku, et al.
Publicado: (2019)

Assessment and diagnostic accuracy of lymph node status to predict stage III colon cancer using computed tomography
por: Rollvén, Erik, et al.
Publicado: (2017)

Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence.
por: Jahkola, T., et al.
Publicado: (1998)

Gastrointestinal cancer-associated antigen CA 19-9 in histological specimens of pancreatic tumours and pancreatitis.
por: Haglund, C., et al.
Publicado: (1986)

Difference in tissue expression of tumour markers CA 19-9 and CA 50 in hepatocellular carcinoma and cholangiocarcinoma.
por: Haglund, C., et al.
Publicado: (1991)

Ductal Breast Carcinoma In Situ: Mammographic Features and Its Relation to Prognosis and Tumour Biology in a Population Based Cohort
por: Zhou, Wenjing, et al.
Publicado: (2017)

Editorial: Latest Advances on Excitatory Synapse Biology
por: Huber, Kimberly M., et al.
Publicado: (2021)

Breast MRI and tumour biology predict axillary lymph node response to neoadjuvant chemotherapy for breast cancer
por: Al-Hattali, Samia, et al.
Publicado: (2019)

Advanced Multivariate Statistics with Matrices
por: Kollo, Tonu, et al.
Publicado: (2005)

Identification of prognostic factors in canine mammary malignant tumours: a multivariable survival study
por: Santos, Andreia A, et al.
Publicado: (2013)

Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9.
por: Haglund, C., et al.
Publicado: (1989)

In vitro cytotoxic drug sensitivity testing of human tumour xenografts grown as multicellular tumour spheroids.
por: Jones, A. C., et al.
Publicado: (1982)

Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families
por: Eerola, Hannaleena, et al.
Publicado: (2005)

Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines.
por: Liebmann, J. E., et al.
Publicado: (1993)

Anti-tumour cytotoxicity of poly(A)-containing messenger RNA isolated from tumour-specific immunogenic RNA.
por: Greenup, C. J., et al.
Publicado: (1978)

Study of the cytotoxicity of asiaticoside on rats and tumour cells
por: Al-Saeedi, Fatma J
Publicado: (2014)

Cytotoxicity of adriamycin to tumour cells in vivo and in vitro.
por: Martin, W. M., et al.
Publicado: (1980)

Recent advances in descriptive multivariate analysis
Publicado: (1995)

Genomic profile of advanced breast cancer in circulating tumour DNA
por: Kingston, Belinda, et al.
Publicado: (2021)

Macrophages promote angiogenesis in human breast tumour spheroids in vivo
por: Bingle, L, et al.
Publicado: (2006)

Segmentation of biological multivariate time-series data
por: Omranian, Nooshin, et al.
Publicado: (2015)

Tumour-associated trypsin inhibitor (TATI) in human ovarian cyst fluid. Comparison with CA 125 and CEA.
por: Halila, H., et al.
Publicado: (1987)

Proceedings: Separation of subpopulations of rat lymph node cells cytotoxic for tumour target cells and capable of inhibiting cytotoxicity in vitro.
por: Rees, R. C., et al.
Publicado: (1975)

Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours
por: Iacovazzo, Donato, et al.
Publicado: (2019)

Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2 and mutation-negative breast cancer families
por: Eerola, Hannaleena, et al.
Publicado: (2005)

Tumour-associated trypsin inhibitor, TATI, in patients with pancreatic cancer, pancreatitis and benign biliary diseases.
por: Haglund, C., et al.
Publicado: (1986)

Recent advances in the biology of human circulating tumour cells and metastasis
por: Gkountela, Sofia, et al.
Publicado: (2016)

Advances in Human Tumour Prevention, Detection and Characterization. Vol. 3. Biological Characterization of Human Tumours
por: Bazill, G. W.
Publicado: (1976)

Multivariate analysis
por: Krzanowski, W J, et al.
Publicado: (1994)

Tumour immune microenvironment biomarkers predicting cytotoxic chemotherapy efficacy in colorectal cancer
por: Wilkinson, Kate, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3c6fjprjcpf3vnngqi83ncci2v